Chronic Hepatitis B: Treat all Who Are Viremic? Are the New Nucleos(t)ide Analogs Better than the Old Nucleos(t)ide Analogs? What Is the Current Status of Hepatitis B Virus Viro-Immunology? Novel Assays to Solve the Clinical and Scientific Challenges of Chronic Hepatitis B Overview of New Targets for Hepatitis B Virus: Immune Modulators, Interferons, Bifunctional Peptides, Therapeutic Vaccines and Beyond Novel Drug Development in Chronic Hepatitis B Infection: Capsid Assembly Modulators and Nucleic Acid Polymers Targeting Hepatitis B Virus DNA Using Designer Gene Editors Maternal-to-Child Transmission of Hepatitis B Virus and Hepatitis Delta Virus State of the Art: Test all for Anti-Hepatitis D Virus and Reflex to Hepatitis D Virus RNA Polymerase Chain Reaction Quantification Triple Threat: HDV, HBV, HIV Coinfection What Is the Real Epidemiology of Hepatitis D Virus and Why so Many Mixed Messages? What is the Path Forward to Treat Hepatitis Delta Virus?: Old Treatments and New Options Test All for Hepatitis B Virus: Link to Care and Treatment if Quantitative DNA Positive, Vaccinate if Susceptible.